Mucinous Ovarian Cancer Clinical Trials 
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.Carboplatin and Paclitaxel or Oxaliplatin and Capecitabine, With or Without Bevacizumab, as First-Line Therapy in Treating Patients With Newly Diagnosed Stage II, Stage III, Stage IV, or Recurrent Stage I Epithelial Ovarian Cancer or Fallopian Tube Cancer
Conditions:  Ovarian Mucinous Cystadenocarcinoma;  Ovarian Mucinous Cystadenoma With Proliferating Activity;  Recurrent Fallopian Tube Cancer;  Recurrent Ovarian Epithelial Cancer;  Stage IA Fallopian Tube Cancer;  Stage IA Ovarian Epithelial Cancer;  Stage IB Fallopian Tube Cancer;  Stage IB Ovarian Epithelial Cancer;  Stage IC Fallopian Tube Cancer;  Stage IC Ovarian Epithelial Cancer;  Stage IIA Fallopian Tube Cancer;  Stage IIA Ovarian Epithelial Cancer;  Stage IIB Fallopian Tube Cancer;  Stage IIB Ovarian Epithelial Cancer;  Stage IIC Fal...
Source: ClinicalTrials.gov - March 4, 2010 Category: Research Source Type: clinical trials
Carboplatin and Paclitaxel or Oxaliplatin and Capecitabine With or Without Bevacizumab as First-Line Therapy in Treating Patients With Newly Diagnosed Stage II-IV or Recurrent Stage I Epithelial Ovarian or Fallopian Tube Cancer
Conditions:  Borderline Ovarian Mucinous Tumor;  Ovarian Mucinous Cystadenocarcinoma;  Recurrent Fallopian Tube Carcinoma;  Recurrent Ovarian Carcinoma;  Stage IA Fallopian Tube Cancer;  Stage IA Ovarian Cancer;  Stage IB Fallopian Tube Cancer;  Stage IB Ovarian Cancer;  Stage IC Fallopian Tube Cancer;  Stage IC Ovarian Cancer;  Stage IIA Fallopian Tube Cancer;  Stage IIA Ovarian Cancer;  Stage IIB Fallopian Tube Cancer;  Stage IIB Ovarian Cancer;  Stage IIC Fallopian Tube Cancer;  Stage IIC Ovarian Cancer;  Stage IIIA Fallopian TubeÂ...
Source: ClinicalTrials.gov - March 4, 2010 Category: Research Source Type: clinical trials
Carboplatin and Paclitaxel or Oxaliplatin and Capecitabine With or Without Bevacizumab as First-Line Therapy in Treating Patients With Newly Diagnosed Stage II-IV or Recurrent Stage I Epithelial Ovarian or Fallopian Tube Cancer
Conditions:  Borderline Ovarian Mucinous Tumor;  Ovarian Mucinous Cystadenocarcinoma;  Recurrent Fallopian Tube Carcinoma;  Recurrent Ovarian Carcinoma;  Stage IA Fallopian Tube Cancer;  Stage IA Ovarian Cancer;  Stage IB Fallopian Tube Cancer;  Stage IB Ovarian Cancer;  Stage IC Fallopian Tube Cancer;  Stage IC Ovarian Cancer;  Stage IIA Fallopian Tube Cancer;  Stage IIA Ovarian Cancer;  Stage IIB Fallopian Tube Cancer;  Stage IIB Ovarian Cancer;  Stage IIC Fallopian Tube Cancer;  Stage IIC Ovarian Cancer;  Stage IIIA Fallopian TubeÂ...
Source: ClinicalTrials.gov - March 4, 2010 Category: Research Source Type: clinical trials
Carboplatin and Paclitaxel or Oxaliplatin and Capecitabine With or Without Bevacizumab as First-Line Therapy in Treating Patients With Newly Diagnosed Stage II-IV or Recurrent Stage I Epithelial Ovarian or Fallopian Tube Cancer
Conditions:  Borderline Ovarian Mucinous Tumor;  Ovarian Mucinous Cystadenocarcinoma;  Recurrent Fallopian Tube Carcinoma;  Recurrent Ovarian Carcinoma;  Stage IA Fallopian Tube Cancer;  Stage IA Ovarian Cancer;  Stage IB Fallopian Tube Cancer;  Stage IB Ovarian Cancer;  Stage IC Fallopian Tube Cancer;  Stage IC Ovarian Cancer;  Stage IIA Fallopian Tube Cancer;  Stage IIA Ovarian Cancer;  Stage IIB Fallopian Tube Cancer;  Stage IIB Ovarian Cancer;  Stage IIC Fallopian Tube Cancer;  Stage IIC Ovarian Cancer;  Stage IIIA Fallopian TubeÂ...
Source: ClinicalTrials.gov - March 4, 2010 Category: Research Source Type: clinical trials
Carboplatin and Paclitaxel or Oxaliplatin and Capecitabine, With or Without Bevacizumab, as First-Line Therapy in Treating Patients With Newly Diagnosed Stage II, Stage III, Stage IV, or Recurrent Stage I Epithelial Ovarian Cancer or Fallopian Tube Cancer
Conditions:  Ovarian Mucinous Cystadenocarcinoma;  Ovarian Mucinous Cystadenoma With Proliferating Activity;  Recurrent Fallopian Tube Cancer;  Recurrent Ovarian Epithelial Cancer;  Stage IA Fallopian Tube Cancer;  Stage IA Ovarian Epithelial Cancer;  Stage IB Fallopian Tube Cancer;  Stage IB Ovarian Epithelial Cancer;  Stage IC Fallopian Tube Cancer;  Stage IC Ovarian Epithelial Cancer;  Stage IIA Fallopian Tube Cancer;  Stage IIA Ovarian Epithelial Cancer;  Stage IIB Fallopian Tube Cancer;  Stage IIB Ovarian Epithelial Cancer;  Stage IIC Fal...
Source: ClinicalTrials.gov - March 4, 2010 Category: Research Source Type: clinical trials
Carboplatin and Paclitaxel or Oxaliplatin and Capecitabine With or Without Bevacizumab as First-Line Therapy in Treating Patients With Newly Diagnosed Stage II-IV or Recurrent Stage I Epithelial Ovarian or Fallopian Tube Cancer
Conditions:  Borderline Ovarian Mucinous Tumor;  Ovarian Mucinous Cystadenocarcinoma;  Recurrent Fallopian Tube Carcinoma;  Recurrent Ovarian Carcinoma;  Stage IA Fallopian Tube Cancer;  Stage IA Ovarian Cancer;  Stage IB Fallopian Tube Cancer;  Stage IB Ovarian Cancer;  Stage IC Fallopian Tube Cancer;  Stage IC Ovarian Cancer;  Stage IIA Fallopian Tube Cancer;  Stage IIA Ovarian Cancer;  Stage IIB Fallopian Tube Cancer;  Stage IIB Ovarian Cancer;  Stage IIC Fallopian Tube Cancer;  Stage IIC Ovarian Cancer;  Stage IIIA Fallopian TubeÂ...
Source: ClinicalTrials.gov - March 4, 2010 Category: Research Source Type: clinical trials
Carboplatin and Paclitaxel or Oxaliplatin and Capecitabine With or Without Bevacizumab as First-Line Therapy in Treating Patients With Newly Diagnosed Stage II-IV or Recurrent Stage I Epithelial Ovarian or Fallopian Tube Cancer
Conditions:  Borderline Ovarian Mucinous Tumor;  Ovarian Mucinous Cystadenocarcinoma;  Recurrent Fallopian Tube Carcinoma;  Recurrent Ovarian Carcinoma;  Stage IA Fallopian Tube Cancer;  Stage IA Ovarian Cancer;  Stage IB Fallopian Tube Cancer;  Stage IB Ovarian Cancer;  Stage IC Fallopian Tube Cancer;  Stage IC Ovarian Cancer;  Stage IIA Fallopian Tube Cancer;  Stage IIA Ovarian Cancer;  Stage IIB Fallopian Tube Cancer;  Stage IIB Ovarian Cancer;  Stage IIC Fallopian Tube Cancer;  Stage IIC Ovarian Cancer;  Stage IIIA Fallopian TubeÂ...
Source: ClinicalTrials.gov - March 4, 2010 Category: Research Source Type: clinical trials
Carboplatin and Paclitaxel or Oxaliplatin and Capecitabine With or Without Bevacizumab as First-Line Therapy in Treating Patients With Newly Diagnosed Stage II-IV or Recurrent Stage I Epithelial Ovarian or Fallopian Tube Cancer
Conditions:  Borderline Ovarian Mucinous Tumor;  Ovarian Mucinous Cystadenocarcinoma;  Recurrent Fallopian Tube Carcinoma;  Recurrent Ovarian Carcinoma;  Stage IA Fallopian Tube Cancer;  Stage IA Ovarian Cancer;  Stage IB Fallopian Tube Cancer;  Stage IB Ovarian Cancer;  Stage IC Fallopian Tube Cancer;  Stage IC Ovarian Cancer;  Stage IIA Fallopian Tube Cancer;  Stage IIA Ovarian Cancer;  Stage IIB Fallopian Tube Cancer;  Stage IIB Ovarian Cancer;  Stage IIC Fallopian Tube Cancer;  Stage IIC Ovarian Cancer;  Stage IIIA Fallopian TubeÂ...
Source: ClinicalTrials.gov - March 4, 2010 Category: Research Source Type: clinical trials
Carboplatin and Paclitaxel or Oxaliplatin and Capecitabine With or Without Bevacizumab as First-Line Therapy in Treating Patients With Newly Diagnosed Stage II-IV or Recurrent Stage I Epithelial Ovarian or Fallopian Tube Cancer
Conditions:  Borderline Ovarian Mucinous Tumor;  Ovarian Mucinous Cystadenocarcinoma;  Recurrent Fallopian Tube Carcinoma;  Recurrent Ovarian Carcinoma;  Stage IA Fallopian Tube Cancer;  Stage IA Ovarian Cancer;  Stage IB Fallopian Tube Cancer;  Stage IB Ovarian Cancer;  Stage IC Fallopian Tube Cancer;  Stage IC Ovarian Cancer;  Stage IIA Fallopian Tube Cancer;  Stage IIA Ovarian Cancer;  Stage IIB Fallopian Tube Cancer;  Stage IIB Ovarian Cancer;  Stage IIC Fallopian Tube Cancer;  Stage IIC Ovarian Cancer;  Stage IIIA Fallopian TubeÂ...
Source: ClinicalTrials.gov - March 4, 2010 Category: Research Source Type: clinical trials
Carboplatin and Paclitaxel or Oxaliplatin and Capecitabine With or Without Bevacizumab as First-Line Therapy in Treating Patients With Newly Diagnosed Stage II-IV or Recurrent Stage I Epithelial Ovarian or Fallopian Tube Cancer
Conditions:  Borderline Ovarian Mucinous Tumor;  Ovarian Mucinous Cystadenocarcinoma;  Recurrent Fallopian Tube Carcinoma;  Recurrent Ovarian Carcinoma;  Stage IA Fallopian Tube Cancer;  Stage IA Ovarian Cancer;  Stage IB Fallopian Tube Cancer;  Stage IB Ovarian Cancer;  Stage IC Fallopian Tube Cancer;  Stage IC Ovarian Cancer;  Stage IIA Fallopian Tube Cancer;  Stage IIA Ovarian Cancer;  Stage IIB Fallopian Tube Cancer;  Stage IIB Ovarian Cancer;  Stage IIC Fallopian Tube Cancer;  Stage IIC Ovarian Cancer;  Stage IIIA Fallopian TubeÂ...
Source: ClinicalTrials.gov - March 4, 2010 Category: Research Source Type: clinical trials
